Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
4
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
clinical trials
indiana blog main
indiana top stories
crispr
democrats
eli lilly
gene therapy
glaxosmithkline
ipo
ubiome
venture funding capital
vertex pharmaceuticals
abbvie
acceleron pharma
What
bio
4
×
moves
4
×
roundup
week
america
aren’t
big
biogen
black
bosley's
bosley’s
bridge
bucks
cas
ceo
companies
continue
continues
convoluted
crime
crispr
debut
democrats
departure
developers
diamond
diamond’s
dreams
drug
drugs
editas
exit
fda
gene
guiding
head
headaches
healthcare
help
holding
Language
unset
Current search:
bio
×
fda
×
moves
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More